U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C29H35N3O4.C4H4O4
Molecular Weight 605.6781
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of E-2110

SMILES

OC(=O)\C=C\C(O)=O.CNC(=O)C1=CC=C2C=CN(C3CCN(CCC4=C(OC)C=CC5=C4OC(C)(C)CC5=O)CC3)C2=C1

InChI

InChIKey=MNUJXFRXXTZIIO-WLHGVMLRSA-N
InChI=1S/C29H35N3O4.C4H4O4/c1-29(2)18-25(33)22-7-8-26(35-4)23(27(22)36-29)12-15-31-13-10-21(11-14-31)32-16-9-19-5-6-20(17-24(19)32)28(34)30-3;5-3(6)1-2-4(7)8/h5-9,16-17,21H,10-15,18H2,1-4H3,(H,30,34);1-2H,(H,5,6)(H,7,8)/b;2-1+

HIDE SMILES / InChI

Molecular Formula C29H35N3O4
Molecular Weight 489.6059
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:43:47 UTC 2023
Edited
by admin
on Sat Dec 16 11:43:47 UTC 2023
Record UNII
DN9H25S82Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
E-2110
Code English
FUMARIC ACID; 1-(1-(2-(7-METHOXY-2,2-DIMETHYL-4-OXO-CHROMAN-8-YL)ETHYL)-4-PIPERIDYL)-N-METHYL-INDOLE-6-CARBOXAMIDE
Systematic Name English
1H-INDOLE-6-CARBOXAMIDE, 1-(1-(2-(3,4-DIHYDRO-7-METHOXY-2,2-DIMETHYL-4-OXO-2H-1-BENZOPYRAN-8-YL)ETHYL)-4-PIPERIDINYL)-N-METHYL-, (2E)-2-BUTENEDIOATE
Systematic Name English
E2110
Code English
Code System Code Type Description
CAS
915024-75-8
Created by admin on Sat Dec 16 11:43:47 UTC 2023 , Edited by admin on Sat Dec 16 11:43:47 UTC 2023
PRIMARY
FDA UNII
DN9H25S82Z
Created by admin on Sat Dec 16 11:43:47 UTC 2023 , Edited by admin on Sat Dec 16 11:43:47 UTC 2023
PRIMARY
PUBCHEM
16038980
Created by admin on Sat Dec 16 11:43:47 UTC 2023 , Edited by admin on Sat Dec 16 11:43:47 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
Bottom Line: The plasma concentrations inducing 50% RO (EC50) estimated by both direct and effect compartment models were in good agreement.Dose-dependent therapeutic effects of E2110 on dysregulated micturition in different rat models of pollakiuria were also consistently explained by achievement of 5-HT1A RO by E2110 in a certain range ( 60%).Plasma drug concentrations inducing this RO range and EC50 would accordingly be objective indices in comparing pharmacokinetics-RO relationships between rats and humans.